Podcast: Xpert® MTB/RIF test for diagnosing extrapulmonary tuberculosis and rifampicin resistance

Most Cochrane Reviews look at the effects of interventions on health, but a growing number are providing g evidence on the accuracy of different ways of diagnosing a disease. These were added to in August 2018 by a new review on a test used in the management of tuberculosis. The review’s first author, Mikashmi Kohli from McGill University in Montreal Canada, sets the scene and tells us what they found in this podcast.